{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:39Z","timestamp":1793413419491,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jhep.2020.11.010","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T18:58:16Z","timestamp":1621796296000},"page":"S101-S117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"special_numbering":"S1","title":["Management of bacterial and fungal infections in cirrhosis: The MDRO challenge"],"prefix":"10.1016","volume":"75","author":[{"given":"Javier","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-5830","authenticated-orcid":false,"given":"Salvatore","family":"Piano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-3283","authenticated-orcid":false,"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-9524","authenticated-orcid":false,"given":"Emmanuel Q.","family":"Wey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.11.010_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/hep.23264","article-title":"Severe sepsis in cirrhosis","volume":"50","author":"Gustot","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2020.11.010_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fernandez","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.010_bib5","article-title":"PREDICT identifies precipitating events associated with clinical course of acutely decompensated cirrhosis","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib6","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.010_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib8","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.010_bib9","doi-asserted-by":"crossref","first-page":"546.e1","DOI":"10.1016\/j.cmi.2017.08.001","article-title":"A\u00a0prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients","volume":"24","author":"Bartoletti","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2020.11.010_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2014.03.021","article-title":"Epidemiology and outcomes of bloodstream infection in patients with cirrhosis","volume":"61","author":"Bartoletti","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib11","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized cirrhotic patients: the NACSELD experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.010_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2016.08.006","article-title":"The challenges of multi-drug-resistance in Hepatology","volume":"65","author":"Fern\u00e1ndez","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.010_bib14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cgh.2012.08.017","article-title":"High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center","volume":"10","author":"Tandon","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.010_bib17","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","author":"Wong","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jhep.2011.11.010","article-title":"Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare andnosocomial spontaneous bacterial peritonitis","volume":"56","author":"Ariza","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.010_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2036.2012.05076.x","article-title":"Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study","volume":"35","author":"Reuken","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.11.010_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","article-title":"Cirrhotic patients are at risk for health care-associated bacterial infections","volume":"8","author":"Merli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-314324","article-title":"Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections","volume":"67","author":"Piano","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.010_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/liv.13195","article-title":"The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study","volume":"37","author":"Salerno","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.010_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1590-8658(01)80134-1","article-title":"Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study","volume":"33","author":"Borzio","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/liv.13239","article-title":"Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis","volume":"37","author":"Fern\u00e1ndez","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.010_bib26","doi-asserted-by":"crossref","first-page":"h6420","DOI":"10.1136\/bmj.h6420","article-title":"Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications","volume":"352","author":"Iredell","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2020.11.010_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of beta-lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jhep.2020.11.010_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/nyas.12023","article-title":"Proliferation and significance of clinically relevant \u03b2-lactamases","volume":"1277","author":"Bush","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jhep.2020.11.010_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 6","key":"10.1016\/j.jhep.2020.11.010_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2005.01264.x","article-title":"The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria","author":"Walsh","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2020.11.010_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01076-18","article-title":"Past and present perspectives on \u03b2-Lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkn444","article-title":"Redefining extended-spectrum beta-lactamases: balancing science and clinical need","volume":"63","author":"Giske","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00397-20","article-title":"Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline","author":"Boyd","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2007.01681.x","article-title":"Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium","volume":"13","author":"Mesaros","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2020.11.010_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijmm.2011.10.001","article-title":"Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies","volume":"302","author":"Li","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jhep.2020.11.010_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568026013395605","article-title":"Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance","volume":"1","author":"Poole","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jhep.2020.11.010_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/46.6.885","article-title":"Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa","volume":"46","author":"Li","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eri.09.108","article-title":"Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy","volume":"8","author":"Zavascki","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jhep.2020.11.010_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/antibiotics9040205","article-title":"Acinetobacter baumannii resistance: a real challenge for clinicians","volume":"9","author":"V\u00e1zquez-L\u00f3pez","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jhep.2020.11.010_bib40","doi-asserted-by":"crossref","first-page":"a025221","DOI":"10.1101\/cshperspect.a025221","article-title":"\u03b2-Lactam resistance mechanisms: gram-positive bacteria and Mycobacterium tuberculosis","volume":"6","author":"Fisher","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/jb.158.2.513-516.1984","article-title":"Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus","volume":"158","author":"Hartman","year":"1984","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jhep.2020.11.010_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jhep.2020.11.010_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/AAC.28.3.397","article-title":"Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus","volume":"28","author":"Utsui","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib44","doi-asserted-by":"crossref","first-page":"25-39","DOI":"10.1016\/j.drup.2018.10.002","article-title":"Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature","volume":"40","author":"Bender","year":"2018","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jhep.2020.11.010_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 6","key":"10.1016\/j.jhep.2020.11.010_bib46","first-page":"vi1","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"55","author":"Moore","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.010_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087870","article-title":"Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 system","volume":"9","author":"Machen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.11.010_bib49","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/jac\/dkaa043","article-title":"Comparison of two multiplex immunochromatographic assays for the rapid detection of major carbapenemases in Enterobacterales","volume":"75","author":"Bogaerts","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib50","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2017.06.013","article-title":"Sepsis in alcohol-related liver disease","volume":"67","author":"Gustot","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gutjnl-2011-300779","article-title":"Spontaneous bacterial peritonitis: recent guidelines and beyond","volume":"61","author":"Wiest","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.010_bib52","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.010_bib53","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.28330","article-title":"Antibiotic prophylaxis in cirrhosis: good and bad","volume":"63","author":"Fern\u00e1ndez","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.010_bib54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/MCG.0b013e3182506dbb","article-title":"The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis","volume":"46","author":"Hanouneh","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.010_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/jgh.12070","article-title":"Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis","volume":"28","author":"Vlachogiannakos","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-015-9688-z","article-title":"Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study","volume":"10","author":"Assem","year":"2016","journal-title":"Hepatol Int"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2020.11.010_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13434","article-title":"Review article: the antimicrobial effects of rifaximin on the gut microbiota","volume":"43","author":"DuPont","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.11.010_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093909","article-title":"Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites","volume":"9","author":"Lutz","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.jhep.2020.11.010_bib59","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1128\/JCM.00820-15","article-title":"Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization","volume":"53","author":"Crum-Cianflone","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2020.11.010_bib60","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomized trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.11.010_bib61","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fernandez","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib62","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/S0168-8278(20)30751-0","article-title":"ATTIRE: albumin to prevent infection in chronic liver failure: an interventional randomised controlled trial","volume":"73","author":"China","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib63","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.010_bib64","first-page":"12A","article-title":"Granulocyte-colony stimulatin factor to treat acute-on-chronic liver failure (Graft Trial): interim analysis of the first randomized European multicentre trial","volume":"70","author":"Engelmann","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.010_bib65","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eimc.2015.12.013","article-title":"Microbiological methods for surveillance of carrier status of multiresistant bacteria","volume":"35","author":"Oteo","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jhep.2020.11.010_bib66","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijantimicag.2016.08.021","article-title":"Colonisation with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis","volume":"48","author":"Alevizakos","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.010_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186195","article-title":"Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study","volume":"12","author":"McConville","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.010_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201688","article-title":"Relationship between digestive tract colonization and subsequent ventilator-associated pneumonia related to ESBL-producing Enterobacteriaceae","volume":"13","author":"Houard","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.11.010_bib69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/tid.12169","article-title":"Risk factors associated with preoperative fecal carriage of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in liver transplant recipients","volume":"16","author":"Bert","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib70","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3201\/eid1806.110139","article-title":"Pretransplant fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and infection after liver transplant, France","volume":"18","author":"Bert","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S0950268801006288","article-title":"Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis","volume":"127","author":"Campillo","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhep.2020.11.010_bib72","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","article-title":"Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis","volume":"56","author":"Arabi","year":"2012","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2020.11.010_bib73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38","author":"Piano","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.010_bib74","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-Day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.11.010_bib75","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/cc7774","article-title":"Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?","volume":"13","author":"Pea","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2020.11.010_bib76","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jhep.2020.11.010_bib78","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/18.3.324","article-title":"Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver","volume":"18","author":"Westphal","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib79","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2174\/138920111798808248","article-title":"Physiological changes in the critically ill patient with sepsis","volume":"12","author":"Hosein","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jhep.2020.11.010_bib80","first-page":"7","article-title":"Choosing an antibiotic on the basis of pharmacodynamics","volume":"77","author":"Craig","year":"1998","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jhep.2020.11.010_bib81","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1345\/aph.1L638","article-title":"Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria","volume":"43","author":"Moriyama","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhep.2020.11.010_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2110-5820-2-37","article-title":"Continuous beta-lactam infusion in critically ill patients: the clinical evidence","volume":"2","author":"Abdul-Aziz","year":"2012","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jhep.2020.11.010_bib83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jhep.2020.11.010_bib84","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/cid\/ciz032","article-title":"Extended infusion of \u03b2-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study","volume":"69","author":"Bartoletti","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib85","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/0016-5085(91)90677-D","article-title":"Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients","volume":"100","author":"Runyon","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.010_bib86","doi-asserted-by":"crossref","first-page":"j3418","DOI":"10.1136\/bmj.j3418","article-title":"The antibiotic course has had its day","volume":"358","author":"Llewelyn","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2020.11.010_bib87","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1093\/jac\/dky295","article-title":"Effectiveness of ceftazidime\/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae","volume":"73","author":"Sousa","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K.\u00a0pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00567-17","article-title":"Meropenem-vaborbactam tested against contemporary gram-negative isolates collected worldwide during 2014, including carbapenem-resistant, KPC-producing, multidrug-resistant, and extensively drug-resistant Enterobacteriaceae","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib90","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jac\/dkw374","article-title":"Efficacy of ceftolozane\/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials","volume":"72","author":"Popejoy","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2020.11.010_bib91","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2020.11.010_bib92","doi-asserted-by":"crossref","first-page":"115012","DOI":"10.1016\/j.diagmicrobio.2020.115012","article-title":"In\u00a0vitro activity of cefiderocol, a novel siderophore cephalosporin, against gram-negative bacilli isolated from patients in Canadian intensive care units","volume":"97","author":"Golden","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib93","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib94","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Acute-on chronic liver failure","volume":"57","author":"Jalan","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.010_bib95","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/imr.12454","article-title":"How neutrophils kill fungi","volume":"273","author":"Gazendam","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2020.11.010_bib96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.471","article-title":"Prediction of fungal infection development and their impact on survival using the NACSELD cohort","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"20","key":"10.1016\/j.jhep.2020.11.010_bib97","article-title":"Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study","volume":"S1198-743X","author":"Bartoletti","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2020.11.010_bib98","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib99","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00134-017-4731-2","article-title":"Intensive care medicine research agenda on invasive fungal infection in critically ill patients","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib100","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib101","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/JCM.01241-08","article-title":"Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol","volume":"47","author":"Gherna","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2020.11.010_bib102","article-title":"Quantification of 1,3-\u03b2-d-glucan by Wako \u03b2-glucan assay for rapid exclusion of invasive fungal infections in critical patients: a diagnostic test accuracy study","author":"Cento","year":"2000","journal-title":"Mycoses"},{"key":"10.1016\/j.jhep.2020.11.010_bib103","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","article-title":"Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study","volume":"47","author":"Boch","year":"2018","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jhep.2020.11.010_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01487-19","article-title":"Updates in laboratory diagnostics for invasive fungal infections","volume":"58","author":"Terrero-Salcedo","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2020.11.010_bib105","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270006297227","article-title":"Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment","volume":"47","author":"Dowell","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jhep.2020.11.010_bib107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.11.010_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2020.11.010_bib109","first-page":"149","article-title":"Clinical hepatotoxicity associated with antifungal agents","volume":"16","author":"Kyriakidis","year":"2017","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820337624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820337624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:41:27Z","timestamp":1759174887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820337624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":109,"alternative-id":["S0168827820337624"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.010","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of bacterial and fungal infections in cirrhosis: The MDRO challenge","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}